Hikma Pharmaceutical | HIK - Ebitda



Hikma Pharmaceutical reported $369M in EBITDA for its fiscal semester ending in December of 2024.


Ebitda Change Date
Almirall EUR 76.3M 8.43M Mar/2025
argenx SE 288.02M 84.53M Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
Autolus Therapeutics Ltd -62937000 10.93M Mar/2025
Bayer EUR 236M 3.35B Jun/2025
Fresenius EUR 828M 88M Jun/2025
Galapagos EUR -158708000 177.84M Mar/2025
Genmab DKK 376M 172M Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 139M Dec/2024
Merck EUR 1.46B 45M Jun/2025
Orion EUR 118.6M 27.1M Jun/2025
Recordati EUR 226.19M 21.6M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 1.89B 971M Jun/2025
UCB EUR 1.37B 715M Dec/2024